26 September 2017: Articles
Klebsiella Pneumoniae Liver Abscess: A Case Series of Six Asian Patients
Rare coexistence of disease or pathology
Katerina G. Oikonomou E 1, Myint Aye F 1*DOI: 10.12659/AJCR.905191
Am J Case Rep 2017; 18:1028-1033
Abstract
BACKGROUND: Liver abscesses represent a serious infection of hepatic parenchyma and are associated with significant morbidity and mortality. The emergence of a new hypervirulent variant of Klebsiella pneumoniae, which can cause serious infections in the Asian population, is under investigation. We report a case series of six Asian patients hospitalized at our institution from January 2013 to November 2015 for liver abscess due to Klebsiella pneumoniae.
CASE REPORT: Charts of six Asian patients were retrospectively reviewed. Four patients were male and two were female. The mean age was 53 years (range: 35–64 years). All patients had no known past medical history of immunodeficiency. Three patients had multiple liver abscesses at the time of initial presentation. In five patients, the source of entry of the pathogenic microorganism was unknown and in one patient the suspected source of entry was the gastrointestinal tract. In three patients there was also concomitant Klebsiella pneumoniae bacteremia. The mean duration of antibiotic treatment was seven weeks and the mean duration of hospital stay was 13.5 days.
CONCLUSIONS: Liver abscess should always be included in the differential diagnosis in cases of sepsis without obvious source and/or in the clinical scenarios of fever, abdominal pain, and liver lesions.
Keywords: Klebsiella pneumoniae, Liver Abscess, Pyogenic, Sepsis
Background
Liver abscesses can develop as a complication of abdominal and biliary infections, or following hematogenous spread, or by contiguity. The etiology of liver abscesses can be bacterial, parasitic and, rarely, fungal [1,2].
The emergence of
We report on a case series of six Asian patients hospitalized at our institution from January 2013 to November 2015 for liver abscess due to
Case Reports
The most important information on patients’ clinical presentation, diagnosis, and management are summarized in Table 1. In our case series, four of the six patients were male and two were female. The mean age was 53 years (range: 35–64 years). One out of six patients had a past medical history of diabetes mellitus; and one out of six patients had a remote past medical history of malignancy but that patient was not on recent chemotherapy. One out of six patients had a past medical history of liver disease (chronic hepatitis B infection). All patients had no known past medical history of immunodeficiency. The initial clinical manifestations included fever-chills, vomiting, and abdominal pain. Three out of six patients met the sepsis criteria upon initial presentation. Three out of six patients were initially admitted to the intensive care unit, and one out of six patients was admitted to the medical intensive care unit for septic shock requiring vasopressors for hemodynamic support.
Three out of six patients also had concomitant bacteremia, but none of the patients had signs and symptoms suggestive of metastatic infection. Upon initial presentation, all patients had abnormal liver function tests and four out of six patients had leukocytosis. Three out of six patients had multiple liver abscesses at the time of initial presentation. In three out of six patients, the abscesses were located on the right liver lobe (Figure 1). In five out of six patients the source of entry of the pathogenic microorganism was unknown, and in one out of six patients the suspected source of entry was the gastrointestinal tract (Table 1). Further work-up with upper endoscopy and colonoscopy for evaluation of possible underlying malignancy was performed for one out of six patients. Five out of six patients underwent drainage of abscesses by Interventional Radiology. The antibiotic choices in all cases included beta-lactams, quinolones, and additionally in five out of six patients the antibiotic regimen also included anaerobic coverage. The mean duration of antibiotic treatment was seven weeks and the mean duration of hospital stay was 13.5 days (range 7–25 days). All patients were discharged in stable condition. All patients had favorable outcomes and satisfactory clinical progress with 0% mortality rate for this case series.
Discussion
The optimal management of pyogenic liver abscess requires appropriate potent broad-spectrum antibiotic regimen tailored to the culture results, in conjunction with source control and abscess drainage and/or surgical intervention. Percutaneous intervention remains the preferred first-line therapeutic choice for liver abscess drainage, especially after the development of advances in imaging technology, the advantages of the simplicity of treatment, and avoidance of general anesthesia and laparotomy [23]. Additionally, needle aspiration can help to identify the responsible etiologic microorganisms and its susceptibilities to antimicrobial agents [1]. In our case series, five out of six patients underwent percutaneous drainage, while in one out of six patients the abscess was not drained due to abscess location just below the diaphragm and the high risk for pneumothorax.
The duration of antibiotic therapy must be determined by clinical response, including the resolution of fever and leukocytosis, and the resolution of the liver abscess as demonstrated by repeat imaging [4,15]. In our case series, all patients underwent repeat imaging during the follow-up period, which confirmed resolution of their abscesses. The mean duration of antibiotic treatment was 7.16 weeks.
It has been shown that diabetes mellitus (DM) can be an important predisposing factor that correlates with a high incidence of K1 serotype liver abscesses due to neutrophil dysfunction and chemotaxis failure [25,26], and that the incidence rate of metastatic infections is higher in patients with DM [23,24]. Metastatic infections are a clinical, diagnostic, and therapeutic challenge and are only diagnosed in one third of the cases on admission [15]. In our case series, no patient developed metastatic infection, despite concomitant bacteremia in three out of six patients.
It has been previously suggested that liver abscesses can be related to gastrointestinal malignancy [27,28]; therefore, further work-up with endoscopy and biliary imaging is indicated.
In our case series, only one out of six patients underwent upper endoscopy and colonoscopy, which were negative for gastrointestinal malignancy.
Pyogenic liver abscesses are considered polymicrobial with estimates ranging from 20–50%, and with frequent presence of anaerobes; thus, anaerobic coverage is warranted since cultures often can be of low yield [25]. In clinical practice, continuation of anaerobic coverage is common even in the absence of anaerobic growth in cultures [29–31]. In a 2015 study by Kim et al., it was suggested that in pyogenic liver abscess cases, anaerobic coverage can be discontinued if
The cornerstones of diagnosis of liver abscess are imaging studies, such as ultrasonography and CT abdomen. In our case series, the initial imaging study of choice for diagnosis of liver abscess was CT abdomen and pelvis, which is consistent with existing literature data. It has been reported that CT was more sensitive than ultrasonography in the detection of liver abscesses, with 98% being clearly identified by CT [3].
The absence of mortality in our case series can be attributed to the increased suspicion for the disease, the early diagnosis, and the prompt initiation of antibiotics combined with source control and drainage of abscess; similar observations have occurred in studies in the past [10,11]. Overall, the prognosis is better for patients with
As mentioned previously,
In our case series,
Conclusions
Liver abscesses due to
References:
1.. Lardière-Deguelte S, Ragot E, Amroun K, Hepatic abscess: Diagnosis and management: J Visc Surg, 2015; 152(4); 231-33, pmid: 25770745
2.. Nakanishi Y, Kayahara T, Yamashita Y, A case of ruptured giant liver cyst complicated by Candida infection: Nihon Shokakibyo Gakkai Zasshi, 2009; 106(7); 1056-52, pmid: 19578314
3.. Ali AH, Smalligan RD, Ahmed M, Khasawneh FA: Int J Gen Med, 2013; 7; 37-32, pmid: 24379693
4.. Meddings L, Myers RP, Hubbard J, A population-based study of pyogenic liver abscesses in the United States: Incidence, mortality, and temporal trends: Am J Gastroenterol, 2010; 105(1); 117-24, pmid: 19888200
5.. Alvarez Pérez JA, González JJ, Baldonedo RF, Clinical course, treatment, and multivariate analysis of risk factors for pyogenic liver abscess: Am J Surg, 2001; 181(2); 177-86, pmid: 11425062
6.. Tsai FC, Huang YT, Chang LY, Wang JT, Pyogenic liver abscess as endemic disease, Taiwan: Emerg Infect Dis, 2008; 14(10); 1592-600, pmid: 18826824
7.. Solomkin JS, Mazuski JE, Bradley JS, Diagnosis and man-agement of complicated intra-abdominal infection in adults and children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America: Clin Infect Dis, 2010; 50(2); 133-34, pmid: 20034345
8.. Hope WW, Vrochides DV, Newcomb WL, Optimal treatment of hepatic abscess: Am Surg, 2008; 74(2); 178-82, pmid: 18306874
9.. Bamberger DM, Outcome of medical treatment of bacterial abscesses without therapeutic drainage: Review of cases reported in the literature: Clin Infect Dis, 1996; 23(3); 592-93, pmid: 8879785
10.. Siu LK, Yeh KM, Lin JC: Lancet Infect Dis, 2012; 12; 881-87, pmid: 23099082
11.. Chen CH, Wu SS, Chang HC, Chang YJ, Initial presentations and final outcomes of primary pyogenic liver abscess: A cross-sectional study: BMC Gastroenterol, 2014; 14; 133, pmid: 25066384
12.. Shon AS, Bajwa RP, Russo TA: Virulence, 2013; 4(2); 107-8, pmid: 23302790
13.. Lin JC, Koh TH, Lee N: Gut Pathog, 2014; 6; 21, pmid: 24987462
14.. Alcántar-Curiel MD, Girón JA: Virulence, 2015; 6(5); 407-9, pmid: 25951089
15.. Lübbert C, Wiegand J, Karlas T, Therapy of liver abscesses: Viszeralmedizin, 2014; 30(5); 334-41, pmid: 26287275
16.. Bilal S, Volz MS, Fiedler T: Emerg Infect Dis, 2014; 20(11); 1939-40, pmid: 25340973
17.. Chung DR, Lee SS, Lee HR: J Infect, 2007; 54; 578-73, pmid: 17175028
18.. Luo Y, Wang Y, Ye L, Yang J: Clin Microbiol Infect, 2014; 20(11); O818-24, pmid: 24804560
19.. Nadasy KA, Domiati-Saad R, Tribble MA: Clin Infect Dis, 2007; 45(3); 25-28
20.. Lee HC, Chuang YC, Yu WL: J Intern Med, 2006; 259; 606-14, pmid: 16704562
21.. Chuang YP, Fang CT, Lai SY: J Infect Dis, 2006; 193; 645-54, pmid: 16453259
22.. Vila A, Cassata A, Pagella H: Open Microbiol J, 2011; 5; 107-13, pmid: 22145012
23.. Liu Y, Wang JY, Jiang W, An increasing prominent disease of Klebsiella pneumoniae liver abscess: Etiology, diagnosis, and treatment: Gastroenterol Res Pract, 2013; 2013; 258514, pmid: 24194749
24.. Dulku G, Mohan G, Samuelson S, Percutaneous aspiration versus catheter drainage of liver abscess: A retrospective review: Australas Med J, 2015; 8(1); 7-18, pmid: 25848403
25.. Kim HA, Chung DR, Yeom JS, Anti-anaerobic coverage is not necessary for Klebsiella pneumoniae liver abscess: A propensity score-matched cohort study: Diagn Microbiol Infect Dis, 2015; 81(1); 60-65, pmid: 25459498
26.. Eltawansy SA, Merchant C, Atluri P, Dwivedi S: Am J Case Rep, 2015; 16; 182-86, pmid: 25807198
27.. Jeong SW, Jang JY, Lee TH, Cryptogenic pyogenic liver abscess as the herald of colon cancer: J Gastroenterol Hepatol, 2012; 27; 248-55, pmid: 21777280
28.. Koo HC, Kim YS, Kim SG, Should colonoscopy be performed in patients with cryptogenic liver abscess?: Clin Res Hepatol Gastroenterol, 2013; 37; 86-92, pmid: 22572520
29.. Baron MJ, Kasper DL, Intraabdominal infections and abscesses: Harrison’s Principles of Internal Medicine, 2012, New York, McGraw-Hill Companies, Inc.
30.. Frey CF, Zhu Y, Suzuki M, Isaji S, Liver abscesses: Surg Clin North Am, 1989; 69; 259-61, pmid: 2648615
31.. Sifri CD, Madoff LC, Infections of the liver and biliary system: Principles and practice of infectious diseases, 2010, Philadelphia, PA, Churchill Livingstone
32.. Melot B, Colot J, Guerrier G: Int J Infect Dis, 2015; 41; 29-31, pmid: 26518064
33.. Yu VL, Hansen DS, Ko WC: Emerg Infect Dis, 2007; 13; 986-93, pmid: 18214169
34.. Yeh KM, Kurup A, Siu LK: J Clin Microbiol, 2007; 45; 466-71, pmid: 17151209
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949976
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950290
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950607
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950985
Most Viewed Current Articles
07 Dec 2021 : Case report
17,691,734
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
164,491
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
113,090
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
59,175
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






